LMD with 0.9% Sodium Chloride Interactions
There are 34 drugs known to interact with LMD with 0.9% Sodium Chloride (dextran, low molecular weight), along with 4 disease interactions. Of the total drug interactions, 25 are major, and 9 are moderate.
Medications known to interact with LMD with 0.9% Sodium Chloride
Note: Showing generic names only.
- abciximab
- acalabrutinib
- apixaban
- ardeparin
- avapritinib
- betrixaban
- cabozantinib
- caplacizumab
- dabigatran
- dalteparin
- danaparoid
- desirudin
- drotrecogin alfa
- edoxaban
- enoxaparin
- fondaparinux
- heparin flush
- horse chestnut
- ibrutinib
- icosapent
- niraparib
- omacetaxine
- omega-3 polyunsaturated fatty acids
- pentoxifylline
- pirtobrutinib
- prasugrel
- ramucirumab
- revakinagene taroretcel
- rivaroxaban
- tafasitamab
- tinzaparin
- tovorafenib
- vorapaxar
- zanubrutinib
LMD with 0.9% Sodium Chloride disease interactions
There are 4 disease interactions with LMD with 0.9% Sodium Chloride (dextran, low molecular weight) which include:
Report options
QR code containing a link to this page
More about LMD with 0.9% Sodium Chloride (dextran, low molecular weight)
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: plasma expanders
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.